ZACKS INVESTMENT MANAGEMENT - VISTAGEN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
ZACKS INVESTMENT MANAGEMENT ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$23,000
-30.3%
12,0000.0%0.00%
-100.0%
Q3 2021$33,000–12,000–0.00%–
 Download
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Performa Ltd (US), LLC 4,900$9,1630.01%
View complete list of VISTAGEN THERAPEUTICS INC shareholders